Trial Outcomes & Findings for Latinos Combating Diabetes (NCT NCT01831921)

NCT ID: NCT01831921

Last Updated: 2019-08-28

Results Overview

Mean hemoglobin A1c in both treatment groups at 6, 12, 18, and 24 months will be assessed.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

225 participants

Primary outcome timeframe

6, 12, 18, and 24 months

Results posted on

2019-08-28

Participant Flow

Baseline and randomization visits began in January 2014 and concluded in June 2016. In a roughly 26-month period, 225 participants were randomized (150 lifestyle intervention; 75 enhanced usual care) to take part in La Comunidad.

Participant milestones

Participant milestones
Measure
Lifestyle Weight-Loss
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by Latino Health Advisors (LHAs). The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
Participants in the Behavioral: Counseling arm will receive two individual sessions with a registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Overall Study
STARTED
150
75
Overall Study
6 Months
122
63
Overall Study
12 Months
120
62
Overall Study
18 Months
90
49
Overall Study
COMPLETED
66
36
Overall Study
NOT COMPLETED
84
39

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Latinos Combating Diabetes

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Lifestyle Weight-Loss
n=150 Participants
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by Latino Health Advisors (LHAs). The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 Participants
Participants in the Behavioral: Counseling arm will receive two individual sessions with registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Total
n=225 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Age, Categorical
Between 18 and 65 years
147 Participants
n=93 Participants
71 Participants
n=4 Participants
218 Participants
n=27 Participants
Age, Categorical
>=65 years
3 Participants
n=93 Participants
4 Participants
n=4 Participants
7 Participants
n=27 Participants
Age, Continuous
41.6 years
STANDARD_DEVIATION 9.0 • n=93 Participants
41.8 years
STANDARD_DEVIATION 9.1 • n=4 Participants
41.6 years
STANDARD_DEVIATION 9.0 • n=27 Participants
Sex: Female, Male
Female
127 Participants
n=93 Participants
64 Participants
n=4 Participants
191 Participants
n=27 Participants
Sex: Female, Male
Male
23 Participants
n=93 Participants
11 Participants
n=4 Participants
34 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
150 Participants
n=93 Participants
75 Participants
n=4 Participants
225 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Region of Enrollment
United States
150 Participants
n=93 Participants
75 Participants
n=4 Participants
225 Participants
n=27 Participants
Hemoglobin A1c
6.0 percent
STANDARD_DEVIATION .30 • n=93 Participants
5.9 percent
STANDARD_DEVIATION .20 • n=4 Participants
5.9 percent
STANDARD_DEVIATION .3 • n=27 Participants
Body Weight
81.9 kilograms
STANDARD_DEVIATION 14.10 • n=93 Participants
80.3 kilograms
STANDARD_DEVIATION 13.1 • n=4 Participants
81.4 kilograms
STANDARD_DEVIATION 13.80 • n=27 Participants
Systolic Blood Pressure
118.5 mmHg
STANDARD_DEVIATION 13.8 • n=93 Participants
116.5 mmHg
STANDARD_DEVIATION 14.5 • n=4 Participants
117.8 mmHg
STANDARD_DEVIATION 14.0 • n=27 Participants
Diastolic Blood Pressure
71.9 mmHg
STANDARD_DEVIATION 8.5 • n=93 Participants
69.9 mmHg
STANDARD_DEVIATION 9.8 • n=4 Participants
71.3 mmHg
STANDARD_DEVIATION 9.0 • n=27 Participants
Fasting Glucose
97.7 mg/dL
STANDARD_DEVIATION 9.9 • n=93 Participants
96.6 mg/dL
STANDARD_DEVIATION 9.6 • n=4 Participants
97.4 mg/dL
STANDARD_DEVIATION 9.8 • n=27 Participants
High Density Lipoprotien (HDL)
45.3 mg/dL
STANDARD_DEVIATION 10.5 • n=93 Participants
46.5 mg/dL
STANDARD_DEVIATION 10.9 • n=4 Participants
45.7 mg/dL
STANDARD_DEVIATION 10.6 • n=27 Participants
Low Density Lipoprotein (LDL)
109.9 mg/dL
STANDARD_DEVIATION 28.50 • n=93 Participants
106.7 mg/dL
STANDARD_DEVIATION 28.10 • n=4 Participants
108.8 mg/dL
STANDARD_DEVIATION 28.40 • n=27 Participants
Triglycerides
142.1 mg/dL
STANDARD_DEVIATION 68.70 • n=93 Participants
140.1 mg/dL
STANDARD_DEVIATION 61.60 • n=4 Participants
141.4 mg/dL
STANDARD_DEVIATION 66.30 • n=27 Participants
Total Cholesterol
183.6 mg/dL
STANDARD_DEVIATION 33.10 • n=93 Participants
181.3 mg/dL
STANDARD_DEVIATION 36.6 • n=4 Participants
182.8 mg/dL
STANDARD_DEVIATION 34.30 • n=27 Participants

PRIMARY outcome

Timeframe: 6, 12, 18, and 24 months

Population: Participant retention at clinic assessment visits is presented below as the number analyzed at each time-point. Follow-up on all participants was at least 12 months; for those participants randomized early in the recruitment process, 18 and 24 month data was collected.

Mean hemoglobin A1c in both treatment groups at 6, 12, 18, and 24 months will be assessed.

Outcome measures

Outcome measures
Measure
Lifestyle Weight-Loss
n=150 Participants
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 Participants
Participants in the Behavioral: Counseling arm will receive two individual sessions with a registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Hemoglobin A1c
6 Months
5.9 percent HbA1c
Standard Deviation .30
5.8 percent HbA1c
Standard Deviation .30
Hemoglobin A1c
12 Months
5.9 percent HbA1c
Standard Deviation .30
5.9 percent HbA1c
Standard Deviation .30
Hemoglobin A1c
18 Months
5.9 percent HbA1c
Standard Deviation .30
5.9 percent HbA1c
Standard Deviation .30
Hemoglobin A1c
24 Months
6.0 percent HbA1c
Standard Deviation .40
6.0 percent HbA1c
Standard Deviation .50

SECONDARY outcome

Timeframe: 6, 12, 18, and 24 months

Population: Participant retention at clinic assessment visits is presented below as the number analyzed at each time-point. Follow-up on all participants was at least 12 months; for those participants randomized early in the recruitment process, 18 and 24 month data was collected.

Mean body weight in both treatment groups at 6, 12, 18, and 24 months will be assessed.

Outcome measures

Outcome measures
Measure
Lifestyle Weight-Loss
n=150 Participants
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 Participants
Participants in the Behavioral: Counseling arm will receive two individual sessions with a registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Body Weight
6 Months
79.2 kilograms
Standard Deviation 14.3
77.4 kilograms
Standard Deviation 13.1
Body Weight
12 Months
79.7 kilograms
Standard Deviation 14.1
79.1 kilograms
Standard Deviation 13.9
Body Weight
18 Months
79.9 kilograms
Standard Deviation 14.5
78.7 kilograms
Standard Deviation 13.6
Body Weight
24 Months
80.0 kilograms
Standard Deviation 13.7
77.3 kilograms
Standard Deviation 12.2

SECONDARY outcome

Timeframe: 6, 12, 18, and 24 months

Population: Participant retention at clinic assessment visits is presented below as the number analyzed at each time-point. Follow-up on all participants was at least 12 months; for those participants randomized early in the recruitment process, 18 and 24 month data was collected.

Mean systolic blood pressure in both treatment groups at 6, 12, 18, and 24 months will be assessed.

Outcome measures

Outcome measures
Measure
Lifestyle Weight-Loss
n=150 Participants
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 Participants
Participants in the Behavioral: Counseling arm will receive two individual sessions with a registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Systolic Blood Pressure
6 Months
117.0 mmHg
Standard Deviation 14.5
113.7 mmHg
Standard Deviation 12.9
Systolic Blood Pressure
12 Months
116.7 mmHg
Standard Deviation 13.2
114.3 mmHg
Standard Deviation 11.9
Systolic Blood Pressure
18 Months
117.1 mmHg
Standard Deviation 12.6
115.6 mmHg
Standard Deviation 12.8
Systolic Blood Pressure
24 Months
119.7 mmHg
Standard Deviation 16.6
116.8 mmHg
Standard Deviation 10.7

SECONDARY outcome

Timeframe: 6, 12, 18, and 24 months

Population: Participant retention at clinic assessment visits is presented below as the number analyzed at each time-point. Follow-up on all participants was at least 12 months; for those participants randomized early in the recruitment process, 18 and 24 month data was collected.

Mean diastolic blood pressure in both treatment groups at 6, 12, 18, and 24 months will be assessed.

Outcome measures

Outcome measures
Measure
Lifestyle Weight-Loss
n=150 Participants
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 Participants
Participants in the Behavioral: Counseling arm will receive two individual sessions with a registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Diastolic Blood Pressure
6 Months
69.5 mmHg
Standard Deviation 9.4
69.2 mmHg
Standard Deviation 9.5
Diastolic Blood Pressure
12 Months
70.0 mmHg
Standard Deviation 9.9
71.2 mmHg
Standard Deviation 8.9
Diastolic Blood Pressure
18 Months
69.3 mmHg
Standard Deviation 9.3
70.4 mmHg
Standard Deviation 8.1
Diastolic Blood Pressure
24 Months
70.5 mmHg
Standard Deviation 9.7
70.7 mmHg
Standard Deviation 8.4

SECONDARY outcome

Timeframe: 6, 12, 18, and 24 months

Population: Participant retention at clinic assessment visits is presented below as the number analyzed at each time-point. Follow-up on all participants was at least 12 months; for those participants randomized early in the recruitment process, 18 and 24 month data was collected.

Mean fasting plasma glucose in both treatment groups at 6, 12, 18, and 24 months will be assessed.

Outcome measures

Outcome measures
Measure
Lifestyle Weight-Loss
n=150 Participants
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 Participants
Participants in the Behavioral: Counseling arm will receive two individual sessions with a registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Fasting Glucose
6 Months
96.3 mg/dL
Standard Deviation 10.3
96.3 mg/dL
Standard Deviation 8.7
Fasting Glucose
12 Months
98.1 mg/dL
Standard Deviation 10.1
96.1 mg/dL
Standard Deviation 11.6
Fasting Glucose
18 Months
98.0 mg/dL
Standard Deviation 11.7
98.6 mg/dL
Standard Deviation 14.2
Fasting Glucose
24 Months
98.2 mg/dL
Standard Deviation 10.5
99.9 mg/dL
Standard Deviation 17.9

SECONDARY outcome

Timeframe: 12, and 24 months

Population: Participant retention at clinic assessment visits is presented below as the number analyzed at each time-point. Follow-up on all participants was at least 12 months; for those participants randomized early in the recruitment process, 24 month data was collected.

Mean total cholesterol in both treatment groups at 12 and 24 months will be assessed.

Outcome measures

Outcome measures
Measure
Lifestyle Weight-Loss
n=150 Participants
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 Participants
Participants in the Behavioral: Counseling arm will receive two individual sessions with a registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Total Cholesterol
12 Months
181.1 mg/dL
Standard Deviation 35.5
180.3 mg/dL
Standard Deviation 36.9
Total Cholesterol
24 Months
184.7 mg/dL
Standard Deviation 40.0
174.4 mg/dL
Standard Deviation 40.3

SECONDARY outcome

Timeframe: 12, and 24 months

Population: Participant retention at clinic assessment visits is presented below as the number analyzed at each time-point. Follow-up on all participants was at least 12 months; for those participants randomized early in the recruitment process, 24 month data was collected.

Mean HDL in both treatment groups at 12 and 24 months will be assessed.

Outcome measures

Outcome measures
Measure
Lifestyle Weight-Loss
n=150 Participants
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 Participants
Participants in the Behavioral: Counseling arm will receive two individual sessions with a registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
High Density Lipoprotein (HDL)
24 Months
46.8 mg/dL
Standard Deviation 10.5
45.5 mg/dL
Standard Deviation 9.8
High Density Lipoprotein (HDL)
12 Months
47.3 mg/dL
Standard Deviation 11.6
47.5 mg/dL
Standard Deviation 11.2

SECONDARY outcome

Timeframe: 12, and 24 months

Population: Participant retention at clinic assessment visits is presented below as the number analyzed at each time-point. Follow-up on all participants was at least 12 months; for those participants randomized early in the recruitment process, 24 month data was collected.

Mean LDL in both treatment groups at 12 and 24 months will be calculated.

Outcome measures

Outcome measures
Measure
Lifestyle Weight-Loss
n=150 Participants
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 Participants
Participants in the Behavioral: Counseling arm will receive two individual sessions with a registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Low Density Lipoprotein (LDL)
12 Months
106.7 mg/dL
Standard Deviation 27.9
106.5 mg/dL
Standard Deviation 31.8
Low Density Lipoprotein (LDL)
24 Months
108.3 mg/dL
Standard Deviation 31.4
101.5 mg/dL
Standard Deviation 25.4

SECONDARY outcome

Timeframe: 12, and 24 months

Population: Participant retention at clinic assessment visits is presented below as the number analyzed at each time-point. Follow-up on all participants was at least 12 months; for those participants randomized early in the recruitment process, 24 month data was collected.

Mean triglycerides in both treatment groups at 12 and 24 months will be calculated.

Outcome measures

Outcome measures
Measure
Lifestyle Weight-Loss
n=150 Participants
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with a registered dietitian during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 Participants
Participants in the Behavioral: Counseling arm will receive two individual sessions with a registered dietitian and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Triglycerides
12 Months
139.7 mg/dL
Standard Deviation 76.6
131.3 mg/dL
Standard Deviation 56.7
Triglycerides
24 Months
147.7 mg/dL
Standard Deviation 74.8
139.3 mg/dL
Standard Deviation 153.9

OTHER_PRE_SPECIFIED outcome

Timeframe: 6, 12, and 24 months

Mean change in fasting insulin from baseline between treatment groups at 6, 12, and 24 months will be assessed.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 6, 12, and 24 months

Mean change in the HOMA IR model from baseline between treatment groups at 6, 12, and 24 months will be assessed.

Outcome measures

Outcome data not reported

Adverse Events

Lifestyle Weight-Loss

Serious events: 4 serious events
Other events: 13 other events
Deaths: 2 deaths

Enhanced Usual Care

Serious events: 1 serious events
Other events: 10 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Lifestyle Weight-Loss
n=150 participants at risk
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with an RD during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 participants at risk
Participants in the Behavioral: Counseling arm will receive two individual sessions with an RD and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
death from non-study related causes (colon cancer)
0.67%
1/150 • Number of events 1 • Information on adverse events and serious adverse events was collected every 6 months for up to 24 months.
0.00%
0/75 • Information on adverse events and serious adverse events was collected every 6 months for up to 24 months.
Vascular disorders
death from non-study related causes (aneurysm)
0.67%
1/150 • Number of events 1 • Information on adverse events and serious adverse events was collected every 6 months for up to 24 months.
0.00%
0/75 • Information on adverse events and serious adverse events was collected every 6 months for up to 24 months.
Surgical and medical procedures
Inpatient hospitalization for surgery
1.3%
2/150 • Number of events 2 • Information on adverse events and serious adverse events was collected every 6 months for up to 24 months.
1.3%
1/75 • Number of events 1 • Information on adverse events and serious adverse events was collected every 6 months for up to 24 months.

Other adverse events

Other adverse events
Measure
Lifestyle Weight-Loss
n=150 participants at risk
Participants in the Behavioral: Lifestyle Weight Loss arm will take part in a group program aimed at achieving modest weight loss (5-7%) through promoting healthy eating and increasing physical activity. The intervention sessions will take place at churches and other community locations and will be coordinated and facilitated by LHAs. The lifestyle intervention will be delivered in 2 phases: Phase 1 will last for 6 months and consist of weekly group meetings; Phase 2 will last for 18 months and consist of one LHA-led group session or one telephone contact from the LHA per month. Participants in this treatment arm will also receive individual visits with an RD during months 1, 3, and 6 of phase 1. Lifestyle Weight Loss: Changing diet, physical activity, and self-regulatory behaviors to promote weight loss.
Enhanced Usual Care
n=75 participants at risk
Participants in the Behavioral: Counseling arm will receive two individual sessions with an RD and monthly newsletters that focus on existing community resources. Counseling: Individual nutrition counseling will be delivered by a registered dietitian.
Musculoskeletal and connective tissue disorders
Joint/Musculoskeletal Pain
8.7%
13/150 • Number of events 150 • Information on adverse events and serious adverse events was collected every 6 months for up to 24 months.
13.3%
10/75 • Number of events 75 • Information on adverse events and serious adverse events was collected every 6 months for up to 24 months.

Additional Information

Mara Z. Vitolins, DrPH, MPH, RDN

Wake Forest School of Medicine

Phone: (336) 716-2886

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place